UK investor appetite for medtech “not keeping pace with innovationâ€, says CEO
Accunea’s CEO, Dr Rob Learney, has expressed concerns that a gap exists between early-stage validation and commercial traction within the UK’s life sciences ecosystem.

GE HealthCare launches new ultrasound system for cardiovascular imaging
AI psychosis sees users ‘co-creating delusions with technology’ – expert
Tempus to acquire AI digital pathology company Paige
Zeiss’ AI-driven tool gets CE mark for OCT scans